Home › Cirrhosis › Texas › Round Rock
Cirrhosis clinical trials in Round Rock, TX
4 studies for Cirrhosis are looking for participants at sites in and around Round Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
RecruitingPhase 2
- Advanced Medical Trials, Georgetown · 9 mi away
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
RecruitingPhase 3
- Advanced Medical Trials, Georgetown · 9 mi away
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
RecruitingPhase 2
- Research Site, Georgetown · 9 mi away
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
RecruitingPhase 3
- Pinnacle Clinical Research, LLC, Georgetown · 9 mi away
About Cirrhosis
Cirrhosis is caused when scar tissue replaces healthy tissue in the liver because of chronic injury. Learn how cirrhosis is diagnosed and treated.
More about Cirrhosis on MedlinePlus
Cirrhosis trials in other cities
- Boston, MA9 studies
- Cleveland, OH9 studies
- Dallas, TX9 studies
- Houston, TX8 studies
- Miami, FL7 studies
- San Antonio, TX7 studies
- Los Angeles, CA6 studies
- New York City, NY5 studies
- Rochester, MN4 studies
- San Diego, CA4 studies
- Durham, NC4 studies
- Indianapolis, IN4 studies
Other studies in Round Rock
- Parkinson's Disease9 studies
- Steatotic Liver Disease8 studies
- Ulcerative Colitis8 studies
- Crohn's Disease6 studies
- Inflammatory Bowel Disease5 studies
- Obesity5 studies
- Non-Small Cell Lung Cancer4 studies
- Type 2 Diabetes4 studies
- Alopecia Areata3 studies
- Colorectal Cancer3 studies
- Mild Cognitive Impairment3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.